• search
Country
CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Client Speak Client Speak

Client Speak

quots
Aurigene Pharmaceutical Services is

a leading CDMO/CRO

that provides contact research and manufacturing services

Contact Now

Resources

Pharmaceutical Services

Oligonucleotide as a novel class of therapeutic modality

JULY 02, 2021

Studies and Research

The influence of formulation development and its route of administration

JANUARY 04, 2021

Pharmaceutical Services

The Importance of Carbohydrate Synthesized Drugs

JANUARY 04, 2021

Biologics Process Development Services

Physiochemical Characterization Services

cGMP Development and Manufacturing Services

Technology meets sustainability - How a complex API development process goes green

Accelerating Drug Discovery Through Innovative Partnerships

Evolution in Pharma Industry and Demand for Integrated CDMO

Peptide Development and Manufacturing

Discovery of MAP855, an Efficacious and Selective MEK1/2 Inhibitor with an ATP-Competitive Mode of Action.

Synthesis of Anti-covid Drug Nirmatrelvir Using Flow Chemistry

Simple and efficient synthesis of imidazoquinoxalines and spiroquinoxalinones via pictect-spengler reaction using Wang resin, Synthetic Communications

×

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack